No Deadlines – Private Funding Opportunities
The Private Funding Opportunities with foundations accepting applications on an ongoing basis, database table below is listed by disease and/or field in alphabetical order. Please type inside the search table below the disease, the specific grant name, name of agency or any other keywords to find more information about any biomedical research grants or educational grants available with no deadlines.
Return to the Calendar of Funding Opportunities here.
| Disease/Field | Funding Agency | Name of Grant / Description | Eligibility / Amount | Deadlines |
|---|---|---|---|---|
| Alzheimer’s Disease and Related Dementias | Alzheimer’s Drug Discovery Foundation (ADDF) | Diagnostics Accelerator: Peripheral Biomarkers Program is soliciting projects to develop biomarkers for Alzheimer’s disease and related dementias accessible from the periphery. | Award amounts will be based on stage and scope of research. | Accepting applications on a rolling basis. |
| Anesthesiology | Foundation for Anesthesia Education and Research | Transition to Independence Grants aim to support the transition of investigators from mentored training-focused support to independent (non-mentored) research support. | $75,000 1 year | Applications will be accepted on a rolling basis |
| Anesthesiology | Foundation for Anesthesia Education and Research | NIA GEMSSTAR is to provide support for early career physician-investigators trained in medical or surgical specialties and early career dentist-scientists to launch careers as future leaders in aging- or geriatric-focused research. | $50,000 over two years | Applications will be accepted on a rolling basis |
| Angelman Syndrome | Foundation for Angelman Syndrome Therapeutics (FAST) | Postdoctoral Fellowships – To increase the number of bright and creative scientists working on Angelman syndrome. Successful applicants for these grants will likely be working in established labs with secure overall funding, which have funding for supplies and any required animal handling costs. | $50,000.00 per year for two years for salary, fringe and consumable costs | Applications will be accepted on a rolling basis |
| Angelman Syndrome | Foundation for Angelman Syndrome Therapeutics (FAST) | FAST-TRAC (Targeted Research to Advance a Cure) awards are designed to catalyze the creation or enhancement of potential treatments for AS with particular emphasis placed on gene modification, disease modification, and symptom-alleviating therapeutics, along with diverse platforms and tools for high-throughput drug screening. | $150,000 per year, one- or two- year grants. | Applications will be accepted on a rolling basis |
| Angelman Syndrome | Foundation for Angelman Syndrome Therapeutics (FAST) | New Investigator Awards granted to promising new scientists that are looking to start a significant research program focusing on translational research in Angelman syndrome, or on technologies specifically relevant to advancing Angelman Syndrome treatment modalities. | $150,000 per year, one- or two- year grants. | Applications will be accepted on a rolling basis |
| Angelman Syndrome | Foundation for Angelman Syndrome Therapeutics (FAST) | Innovation Seed Grant designed to support innovative proof-of-concept research to advance the understanding and treatment of Angelman Syndrome. | Ranging from $10,000 to $50,000. | Applications will be accepted on a rolling basis |
| Ataxia-telangiectasia | A-T Children’s Project | Research Grants for basic science, translational and clinical research grants related to ataxia-telangiectasia. | $75,000 per year up to 2 years | Grants are reviewed on a rolling basis and awarded quickly compared to most other grant-giving organizations. |
| ASXL Congenital Syndromes | ASXL Rare Research endowment (AЯRE) | Basic Scientific and Clinical Research projects focused on advancing understanding of ASXL genes and improving the treatment and management of individuals with congenital ASXL syndromes. | Up to $100,000 for 1 or 2 years. | Proposals are accepted on a continual basis for subsequent review. Decisions will be made within six months of proposal submission. |
| Breast Cancer | Earlier.org – Friends For An Earlier Breast Cancer Test | Innovative Testing Research grant supports pilot research projects focused on improving the detection of early-stage breast cancer. | $50,000 (effective beginning with the 2025 grant cycle) over a 1-3 year period. | On a rolling basis, we accept applications for pilot projects |
| Cancer | American Cancer Society (ACS) | Extramural Discovery Science (EDS) Accelerator Award | $75,000 direct costs for a 1 year project period. No indirect costs allowed. | Applications will be accepted on a rolling basis during the year (i.e., no set deadline). Applications submitted by April 30, 2024, will be reviewed in May 2024. Applications submitted May 1 to August 31, 2024, will be reviewed in September 2024. |
| Clinical Training on these areas:
• Pulmonology |
Mallinckrodt Pharmaceuticals | Clinical Training Program (CTP), through the education and clinical training of HCPs and/or conduct of clinically relevant independent research under a fellowship grant. | For CTP grant requests exceeding $100,000 in funding, the Company will pay 85% of the approved grant amount prior to the funding program initiation. | The Grants Review Committee meets regularly to review all submissions |
| Childhood Arthritis | Childhood Arthritis & Rheumatology Research Alliance (CARRA) | CARRA-Arthritis Foundation Data Analysis Support Grant instructions | $10,000 | Applications accepted on a rolling basis |
| Childhood Brain Tumors | Pediatric Brain Tumor Foundation | Pediatric Low-grade Glioma and Astrocytoma Research Funding | One, two or three-year periods depending on scope and complexity of project | Applications accepted on a rolling basis |
| Colorectal Cancer | Colorectal Cancer Alliance | Project Cure CRC Early-Career Investigator Awards aim to attract early career faculty with original ideas into the field of colorectal cancer research, thereby recruiting and supporting the next generation of CRC research leaders. | Up to $100,000 per year for two years (up to $200,000 total) | On a rolling basis |
| Colorectal Cancer | Colorectal Cancer Alliance | Project Cure CRC Senior Investigator Awards will fund potentially transformative ideas that will accelerate the translation of new therapies and technologies. | Up to $1,000,000 per year for two years (up to $2,000,000 total) | On a rolling basis |
| Colorectal Cancer | Colorectal Cancer Alliance | Project Cure CRC Pilot Awards support investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. | Up to $100,000 per year for two years (up to $200,000 total) | On a rolling basis |
| Colorectal Cancer | Colorectal Cancer Alliance | Project Cure CRC The Team Science Award will support team science, including public-private partnerships, that will drive CRC research to curative science. | Up to $2,000,000 per year for three years (up to $6,000,000 total) | On a rolling basis |
| Cystic Fibrosis | Cystic Fibrosis Foundation (CFF) | Pioneer Award to identify ambitious basic research projects aiming to utilize cutting-edge techniques and strategies that have the potential to discover new genetic-based therapies for cystic fibrosis. | Applicants may propose an amount necessary to complete the proposed research, plus an additional twelve percent (12%) of indirect costs. Up to three (3) years of funding may be requested. |
Rolling. Closes by December 13, 2024 |
| Focused Ultrasound, Brain, Body, Cancer Immunotherapy, Gene and Cell Therapy, Neurodegenerative | Focused Ultrasound Surgery Foundation | Preclinical Research Award funds investigator-initiated preclinical or earlystage research projects that can lead to treatments for disease. | $100,000 | LOIs are accepted at any time. |
| Focused Ultrasound, Brain, Body, Cancer Immunotherapy, Gene and Cell Therapy, Neurodegenerative | Focused Ultrasound Surgery Foundation | Clinical Research Award funds first-in-human and other innovative clinical trials involving the use of image-guided focused ultrasound to treat diseases. | $100,000 | LOIs are accepted at any time. |
| Health Equity | Robert Wood Johnson Foundation (RWJF) | Pioneering Ideas: Exploring the Future to Build a Culture of Health Program seeks proposals that are primed to influence health equity in the future. | The average Pioneer grant in 2019 was $315,031 | Rolling deadlines for the submission of Letters of Inquiry |
| Health Professional Education and Career Development, Clinical Education in the underserved populations, and Graduate Medical Education Reform | Josiah Macy Jr. Foundation | Board Grants are selected three times each year at our board meetings. | Amount varies depending on the budget for 1-2 years. For assistance in preparing your application contact David Gillerman at the Development Office. | Rolling deadlines for the submission of Letters of Inquiry |
| Health Professional Education and Career Development, Clinical Education in the underserved populations, and Graduate Medical Education Reform | Josiah Macy Jr. Foundation | President’s Grants can be given at any time for grants aligned with our priority areas. | $25,000, which includes indirect costs of not more than 10%. For assistance in preparing your application contact David Gillerman at the Development Office. | Rolling deadlines for the submission of Letters of Inquiry |
| Lyme Disease | Bay Area Lyme Foundation | Research Grant funds research and development of novel diagnostics and treatments for Lyme disease. | Funding amount to be determined | Grant proposals are accepted on a rolling basis year round |
| Neuromuscular Diseases | Muscular Dystrophy Association (MDA) | MDA Venture Philanthropy (MVP) is the drug development program, which operates within MDA’s Translational Research program focused on funding the discovery and clinical application of treatments and cures for neuromuscular diseases. | Research and Development up to $300,000, Preclinical up to $500,000 and Early Clinical Phase I/II up to $1 million. | MDA will accept company pitch decks on an ongoing basis to be reviewed individually. |
| Neuroblastoma, Brain Tumors and Sarcomas | Solving Kid’s Cancer | The TDI of SKC only supports clinical research. The organization specifically focuses on novel clinical studies for neuroblastoma, brain tumors and sarcomas. We may fund studies in which additional pediatric cancer types are included in the study protocol. | $50,000 to $600,000 | Proposals are accepted and reviewed throughout the year on a rolling basis. |
| Ovarian Cancer | The Tell Every Amazing Lady® (T.E.A.L) Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation | Medical Research Program offers funding in support of ovarian cancer research studies that are most aligned with that mission as determined by the T.E.A.L.® board of directors and scientific advisory board. | $20,000 per year | Accepting proposal year-round |
| Pain | The MAYDAY Fund | MAYDAY Fund’s current grant-making targets are projects to address the following needs: • Research Bench to Bedside • Pain Thermometer • Knowledge & Networks • Alternative Strategies & Therapies |
Funds unspecified | Ongoing. The Trustees meet 3 times per year to review letters |
| Physical Sciences │Chemistry │Physics | Simons Foundation | Targeted Grants program is intended to support high-risk theoretical mathematics, physics and computer science projects of exceptional promise and scientific importance on a case-by-case basis. | There is no recommended or assumed funding level for this program. | Letters of Intent (LOI) Deadline Rolling |
| Spinal Cord Injury Research | Wings for Life Spinal Cord Research Foundation | The Wings for Life Accelerated Translational Program (ATP) has been specifically designed to be able to accommodate obstacles to efficient clinical translation. | Not specified | No deadlines for clinical proposals for the Accelerated Translational Program (ATP). |
| X syndrome | FRAXA Research Foundation | Fraxa Clinical Trial Grants Highest priority is given to clinical trials of potentially disease-modifying therapeutics which have previously been validated in fragile X animal models. | MD and/or PhD/ Flexible in amount and duration. | Applications may be submitted at any time, but a Letter of Intent (LOI) is essential; initial inquiries should be directed to Dr. Michael Tranfaglia at mtranfaglia@fraxa.org. |
Last updated on January 21, 2025